Creative Biolabs advances liposomal technology to enhance gene therapy drug delivery, promising greater efficacy and safety.

Creative Biolabs has announced advancements in liposomal technology to improve drug delivery systems, particularly for gene therapy. The company offers various liposome types, including cationic and long-circulating, which enhance drug efficacy and bioavailability. With a focus on customer needs and state-of-the-art technologies, Creative Biolabs aims to develop safer and more effective drug delivery methods.

November 12, 2024
3 Articles

Further Reading